104 related articles for article (PubMed ID: 11550283)
1. Identification of four new translocations involving FGFR1 in myeloid disorders.
Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
[TBL] [Abstract][Full Text] [Related]
2. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.
Chen J; Deangelo DJ; Kutok JL; Williams IR; Lee BH; Wadleigh M; Duclos N; Cohen S; Adelsperger J; Okabe R; Coburn A; Galinsky I; Huntly B; Cohen PS; Meyer T; Fabbro D; Roesel J; Banerji L; Griffin JD; Xiao S; Fletcher JA; Stone RM; Gilliland DG
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14479-84. PubMed ID: 15448205
[TBL] [Abstract][Full Text] [Related]
3. ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5.
Smedley D; Demiroglu A; Abdul-Rauf M; Heath C; Cooper C; Shipley J; Cross NC
Neoplasia; 1999 Oct; 1(4):349-55. PubMed ID: 10935490
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan.
Usuki K; Kameda T; Kawano N; Ito T; Hashimoto Y; Shide K; Kawano H; Sekine M; Toyama T; Iizuka H; Sato S; Takeuchi M; Ishizaki J; Maeda K; Nakai M; Yamashita K; Kubuki Y; Shimoda K
Int J Hematol; 2024 Jun; 119(6):722-727. PubMed ID: 38457113
[TBL] [Abstract][Full Text] [Related]
5. Myeloid/lymphoid neoplasm with a novel cryptic
Yang T; Mahmood N; Goldberg B; Cevallos J; Hsu P; Kolitz J; Cohen N; Zhang X
Leuk Lymphoma; 2023 Dec; 64(14):2338-2342. PubMed ID: 37791611
[No Abstract] [Full Text] [Related]
6. Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case report.
Mojarad BA; Crees ZD; Schroeder MC; Xiang Z; Vader J; Sina J; Jacoby M; Frater JL; Duncavage EJ; Spencer DH; Lavine K; Neidich JA; Amarillo I
Cancer Genet; 2024 Jan; 280-281():1-5. PubMed ID: 38056049
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia with LRRFIP1::FGFR1 rearrangement and a complex karyotype.
Qian YW; Wang ES; Sait SJ; Glenn ST
Cancer Genet; 2023 Nov; 278-279():50-54. PubMed ID: 37597337
[TBL] [Abstract][Full Text] [Related]
8. RNA Sequencing Reveals Novel Oncogenic Fusions and Depicts Detailed Fusion Transcripts of FN1-FGFR1 in Phosphaturic Mesenchymal Tumors.
Liu X; Yin X; Li D; Li K; Zhang H; Lu J; Zhou L; Gao J; Wang J; Wu H; Liang Z
Mod Pathol; 2023 Oct; 36(10):100266. PubMed ID: 37391169
[TBL] [Abstract][Full Text] [Related]
9. Different phenotype relapse of myeloid/lymphoid neoplasms with FGFR1 rearrangement with long remission.
Sugiyama M; Arakawa A; Kogure Y; Shirakawa N; Watanabe M; Ito Y; Tanimura K; Tao K; Nakajima M; Watanabe Y; Miyagi-Maeshima A; Fukuhara S; Kataoka K; Izutsu K; Fukuda T; Ogawa C
Pediatr Blood Cancer; 2024 Jan; 71(1):e30721. PubMed ID: 37833848
[No Abstract] [Full Text] [Related]
10. The First Case of B-lymphoblastic Leukemia Associated With t(7;8)(q34;p11.2) and
Cho HE; Han Y; Lee JJ; Park KS; Kim YJ; Cho SY; Yoon HS; Lee WI; Park TS
Ann Lab Med; 2022 Jul; 42(4):485-487. PubMed ID: 35177571
[No Abstract] [Full Text] [Related]
11. Case Report: A novel
Zhang Z; Zhu Y; Wang Z; Zeng Z; Wen L; Zhang L; Chen S
Front Oncol; 2023; 13():1276695. PubMed ID: 38023217
[TBL] [Abstract][Full Text] [Related]
12. Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement.
Loscocco GG; Ascani S; Mannelli F; Zanelli M; Rotunno G; Santi R; Vannucchi AM
Am J Hematol; 2023 Dec; 98(12):1959-1962. PubMed ID: 37435901
[No Abstract] [Full Text] [Related]
13. A novel
Jiménez-Vicente C; Garrote M; López-Guerra M; Villamón E; Guijarro F; Perez-Valencia AI; Martinez-Roca A; Balaguer O; Álvarez-Larrán A; Hernández-Boluda JC; Rovira M; Colomer D; Diaz-Beyá M; Rozman M; Esteve J
Leuk Lymphoma; 2024 Mar; 65(3):394-398. PubMed ID: 38117930
[No Abstract] [Full Text] [Related]
14. 8p11 myeloproliferative syndrome: a review.
Jackson CC; Medeiros LJ; Miranda RN
Hum Pathol; 2010 Apr; 41(4):461-76. PubMed ID: 20226962
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome.
Grand EK; Grand FH; Chase AJ; Ross FM; Corcoran MM; Oscier DG; Cross NC
Genes Chromosomes Cancer; 2004 May; 40(1):78-83. PubMed ID: 15034873
[TBL] [Abstract][Full Text] [Related]
16. Identification of targetable FGFR gene fusions in diverse cancers.
Wu YM; Su F; Kalyana-Sundaram S; Khazanov N; Ateeq B; Cao X; Lonigro RJ; Vats P; Wang R; Lin SF; Cheng AJ; Kunju LP; Siddiqui J; Tomlins SA; Wyngaard P; Sadis S; Roychowdhury S; Hussain MH; Feng FY; Zalupski MM; Talpaz M; Pienta KJ; Rhodes DR; Robinson DR; Chinnaiyan AM
Cancer Discov; 2013 Jun; 3(6):636-47. PubMed ID: 23558953
[TBL] [Abstract][Full Text] [Related]
17. The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11).
Wasag B; Lierman E; Meeus P; Cools J; Vandenberghe P
Haematologica; 2011 Jun; 96(6):922-6. PubMed ID: 21330321
[TBL] [Abstract][Full Text] [Related]
18. Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases.
Vizmanos JL; Hernández R; Vidal MJ; Larráyoz MJ; Odero MD; Marín J; Ardanaz MT; Calasanz MJ; Cross NC
Hematol J; 2004; 5(6):534-7. PubMed ID: 15570299
[TBL] [Abstract][Full Text] [Related]
19. FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma.
Sievers P; Stichel D; Schrimpf D; Sahm F; Koelsche C; Reuss DE; Wefers AK; Reinhardt A; Huang K; Ebrahimi A; Hou Y; Pajtler KW; Pfister SM; Hasselblatt M; Stummer W; Schick U; Hartmann C; Hagel C; Staszewski O; Reifenberger G; Beschorner R; Coras R; Keyvani K; Kohlhof P; Diomedi-Camassei F; Herold-Mende C; Giangaspero F; Rushing E; Giannini C; Korshunov A; Jones DTW; von Deimling A
Acta Neuropathol; 2018 Aug; 136(2):293-302. PubMed ID: 29978331
[TBL] [Abstract][Full Text] [Related]
20. Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and
Wehrli M; Oppliger Leibundgut E; Gattiker HH; Manz MG; Müller AM; Goede JS
Oncologist; 2017 Apr; 22(4):480-483. PubMed ID: 28242791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]